Monitor for any takedown notice under the shelf, which would signal an imminent dilutive offering. The company's history suggests rapid use of registered securities once effective.
JAGX drugs
JAGX drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $0.4043entry
- T+1 · 13d ago +7.87%α +5.50% · $0.4361
- T+5 · 9d ago +3.59%α +0.99% · $0.4188
- T+10 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The SEC declared effective Jaguar Health's S-3 shelf registration (File No. 333-299584), allowing the company to sell up to $75 million of securities. This follows a pattern of frequent dilutive capital raises for a micro-cap biotech with a going-concern audit opinion, creating persistent dilution overhang.
Key Facts
- Effectiveness date: November 5, 2026
- S-3 shelf registration covers up to $75 million of securities
- Company has a $16 million market cap and a history of 23 registration filings in 24 months
- Prior S-1/A registered 41 million shares for resale under a $40 million ELOC
- Company has a going-concern audit opinion
Financial Impact
Potential dilution of up to ~469% of current market cap if the full $75M shelf is drawn at current market prices
Risk Factors
- Imminent dilutive offering likely given capital needs and going-concern status
- Massive dilution potential relative to current $16M market cap
- Existing ELOC and prior shelf carryforward add to overhang
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003454 |
| Document: 9999999995-26-003454-index.html | 9999999995-26-003454 |
| Document: 9999999995-26-003454.txt | 9999999995-26-003454 |
Track record
33 reports on JAGX
7 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +97.54% at T+1 after the Apr 27, 2026 report. 21 of 22 went positive at some point.
Filters
- Nov 20, 20261d ago 8-K Bearish 5/10 Entry $0.2877 Now $0.2270 +21.10% settles Feb 19
- Nov 16, 20265d ago 8-K Bearish 6/10 Entry $0.3864 Now $0.2270 +41.25% settles Feb 12
- Nov 9, 202612d ago 424B5 Bearish 6/10 Entry $0.4361 Now $0.2270 +47.95% settles Feb 5
- Nov 6, 202615d ago 8-K Bearish 6/10 Entry $0.4361 Now $0.2270 +47.95% settles Feb 5
- Nov 6, 202616d ago EFFECT Bearish 5/10 Viewing Entry $0.4043 Now $0.2270 +43.85% settles Feb 4
- Nov 3, 202618d ago S-3/A Bearish 5/10 Entry $0.5575 Now $0.2270 +59.28% settles Feb 1
- Nov 3, 202618d ago 8-K Neutral 2/10 Entry $0.5575 Now $0.2270 −59.28% settles Feb 1
- Oct 29, 202623d ago DEFA14A Bearish 6/10 Entry $2.04 Now $0.2270 +88.87% settles Jan 27
- Oct 28, 202624d ago 8-K Neutral 2/10 Entry $2.04 Now $0.2270 −88.87% settles Jan 27
- Oct 22, 20264w ago S-3 Bearish 5/10 Entry $2.04 Now $0.2270 +88.87% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers